Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Chemosphere|May 10, 2022
Environmental and health impacts of contaminants of emerging concerns: Recent treatment challenges and approachesDeepak Yadav, S Rangabhashiyam, Pramit Verma, et al.
Nanoscale|August 5, 2025
Interfacial engineering of CuSe<sub>2</sub>/FeSe<sub>2</sub> heterojunctions for water splitting: a pathway to high-performance hydrogen and oxygen evolution reactionsSandhyawasini Kumari, Swapna Pahra, Amrita Tripathy, et al.
Frontiers in Immunology|September 29, 2025
Parenteral micronutrient supplementation enhances mammary immune function and colostrum-milk quality by modulating cytokine profiles and oxidative stress in transition crossbred cowsYallappa M Somagond, Pravasini Das, Ajay Kumar Dang, et al.
The New England Journal of Medicine|June 24, 2026
Ten-Year Outcomes after CAR T-Cell Therapy for B-Cell LymphomasMarco Ruella, Luca Paruzzo, Emeline R Chong, et al.
The Review of Scientific Instruments|February 2, 2026
Multi-filter diamond array time-of-flight particle detector in laser-plasma experimentsAngelo M Raso, Edoardo Domenicone, Giada Petringa, et al.
Nature Communications|May 15, 2026
Naïve CD4<sup>+</sup> T-cells and disease status at CART infusion correlate with clinical outcomes in real-world large B-cell lymphoma patients receiving second-line CAR T therapyMichael Schneider, Luca Paruzzo, Federico Stella, et al.
Blood|January 6, 2026
Harnessing the CD2 axis to broaden and enhance the efficacy of CAR T-cell therapiesAlberto Carturan, Mathew G Angelos, Puneeth Guruprasad, et al.
Nature Medicine|January 15, 2026
CD4<sup>+</sup> T cells mediate CAR-T cell-associated immune-related adverse events after BCMA CAR-T cell therapyMatthew Ho, Luca Paruzzo, Julia Han Noll, et al.
Pageof 5